» Articles » PMID: 39988812

Right Ventricular-pulmonary Arterial Coupling and Pulmonary Hypertension in Hemodialysis: Insights into Structural Cardiac Changes and Clinical Implications

Abstract

Objectives: This cross-sectional analysis from the CZecking Heart Failure in patients with advanced Chronic Kidney Disease trial (ISRCTN18275480) examined pulmonary hypertension and right ventricular-pulmonary arterial coupling in patients on chronic hemodialysis. The aims of this analysis were: 1. To analyze relations between pulmonary hypertension and right ventricular-pulmonary arterial coupling with dialysis access flow and current hydration; 2. To analyze structural heart changes associated with right ventricular-pulmonary arterial uncoupling; 3. To reveal the prevalence, etiology and severity of pulmonary hypertension in the Czech hemodialysis population.

Methods: We performed expert echocardiography, vascular access flow measurements, bioimpedance analysis, and laboratory testing in 336 hemodialysis patients.

Results: Pulmonary hypertension was present in 34% (114/336) patients and right ventricular-pulmonary arterial uncoupling was present in 25% of patients with pulmonary hypertension. Only weak associations between the flow of the dialysis arteriovenous access and estimated pulmonary arterial systolic pressure and right ventricular-pulmonary arterial coupling was proved. There was a strong association between hydration status assessed by estimated central venous pressure with pulmonary arterial systolic pressure (Rho 0.6,  < 0.0001) and right ventricular-pulmonary arterial coupling (Rho -0.52,  < 0.0001) and association between overhydration to extracellular water ratio with pulmonary arterial systolic pressure (Rho 0.31,  = 0.0001) and right ventricular-pulmonary arterial coupling (Rho -0.29,  = 0.002). The prevalence of heart failure was significantly higher in patients with right ventricular-pulmonary arterial uncoupling (88% vs. 52%,  = 0.0003).

Conclusion: These findings suggest that optimizing volume status and treating heart failure should be prioritized in hemodialysis patients to prevent pulmonary hypertension progression and right ventricular-pulmonary arterial uncoupling.

References
1.
Nakagawa Y, Nishikimi T, Kuwahara K . Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides. 2018; 111:18-25. DOI: 10.1016/j.peptides.2018.05.012. View

2.
Mukhtar K, Mohkumuddin S, Mahmood S . Frequency of pulmonary hypertension in hemodialysis patients. Pak J Med Sci. 2015; 30(6):1319-22. PMC: 4320723. DOI: 10.12669/pjms.306.5525. View

3.
Block G, Levin N, Port F . Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998; 31(4):607-17. DOI: 10.1053/ajkd.1998.v31.pm9531176. View

4.
Zoccali C, Moissl U, Chazot C, Mallamaci F, Tripepi G, Arkossy O . Chronic Fluid Overload and Mortality in ESRD. J Am Soc Nephrol. 2017; 28(8):2491-2497. PMC: 5533242. DOI: 10.1681/ASN.2016121341. View

5.
Saleh M, El Kilany W, Keddis V, Said T . Effect of high flow arteriovenous fistula on cardiac function in hemodialysis patients. Egypt Heart J. 2018; 70(4):337-341. PMC: 6303531. DOI: 10.1016/j.ehj.2018.10.007. View